Objective: Administration of glucagon (GCG) or GCG-containing co-agonists reduces body weight and increases energy expenditure. These actions appear to be transduced by multiple direct and indirect GCG receptor (GCGR)-dependent mechanisms. Although the canonical GCGR is expressed in brown adipose tissue (BAT) the importance of BAT GCGR activity for the physiological control of body weight, or the response to GCG agonism, has not been defined. Methods: We studied the mechanisms linking GCG action to acute increases in oxygen consumption using wildtype (WT), Ucp1
INTRODUCTION
The proglucagon-derived peptides (PGDPs) are encoded by a single mammalian gene and include glucagon (GCG), oxyntomodulin, glicentin, and two GCG-like peptides, GLP-1 and GLP-2 [1] . The PGDPs control energy intake, gut motility, mucosal integrity, and the absorption, disposal and storage of ingested energy. The prototype member of the PGDP family, 29 amino acid GCG, is produced in and secreted from islet a-cells, and to a lesser extent, from brainstem neurons [1] . The principal biological role of pancreatic GCG is the maintenance of euglycemia through its control of hepatic glucose production [2e4] . GCG exerts its metabolic actions through a single GCG receptor (GCGR) [5] highly expressed in hepatocytes but also detected in brain, heart, kidney, gastrointestinal tract, and both white and brown adipose tissue (WAT and BAT, respectively) [6, 7] . Although less extensively studied, GCG exerts direct actions on adipose tissue, encompassing increased blood flow, stimulation of lipolysis, increased glucose uptake and increased oxygen consumption in WAT and BAT [8e12] . In addition, GCG administration also acutely increases whole body oxygen consumption following administration to animals and humans in vivo [13e 15]. Considerable evidence links sustained GCG administration to the reduction of food intake, enhancement of energy expenditure and weight loss in rodent and human studies [16e18] . Moreover, patients presenting with GCG-producing tumors frequently manifest severe weight loss, through mechanisms that are incompletely understood [19] . Despite several decades of experimentation, the precise processes and cell types contributing to GCG-mediated weight loss remain incompletely understood. Although intracerebroventricular infusion of GCG directly reduces food intake [20] and increases energy expenditure [21] , other studies have demonstrated that the GCG-mediated reduction of food intake requires intact hepatic vagal nerve innervation [22] and rats with surgical BAT denervation exhibit diminished metabolic and mitochondrial responses to exogenous glucagon [23] . The clinical development of investigational GCG-containing multi-agonists, including oxyntomodulin and its derivatives [3, 24, 25] , for the treatment of diabetes and obesity has rekindled interest in whether and how GCGR signaling results in BAT activation and increased energy expenditure [2, 26, 27] . Several studies invoke an indirect role for GCG on BAT and energy expenditure, acting through enhanced blood flow [28] , the sympathetic nervous system (SNS) [29, 30] , or fibroblast growth factor (FGF)21 [31, 32] . However, other studies support a direct role for GCG as an activator of oxygen consumption in BAT [14, 33] . Interestingly, GCG infusion in healthy humans subjected to cold exposure increased energy expenditure without evidence for BAT activation as assessed by positron emission tomography scanning [15] . Here we examined the importance of the BAT GCGR for GCGstimulated energy expenditure in mice and characterized the metabolic phenotype of mice with genetic deletion of the Gcgr in BAT using myogenic factor 5 (Myf5)-Cre. Using BAT cells and explants ex vivo, as well as WT and knockout mice, we demonstrate that GCG acts both directly and indirectly to enhance whole body and BAT oxygen consumption. Nevertheless, the BAT Gcgr is physiologically dispensable for GCG-stimulated increase in energy expenditure, and the adaptive metabolic responses to HFD feeding or prolonged cold exposure.
MATERIALS AND METHODS

Animals
All animal experiments were conducted in accordance with protocols approved by the Toronto Centre for Phenogenomics (TCP) Animal Care Committee. Experiments were performed in group-housed male mice that were maintained on a 12h light/dark cycle at room temperature (RT; 21 C), 4 C, or 30 C and with free access to food and water, except where indicated. Mice were fed either a standard rodent chow diet (RCD; 18% kcal from fat, 2018 Harlan Teklad, Mississauga, ON) or a high-fat diet (HFD; 45% kcal from fat, D12451i, Research Diets, New Brunswick, NJ) for diet-induced obesity analysis. Chronically housed (w12 weeks) 4 C group-housed male mice were placed into nonvented microisolator cages (Ancare) with free access to food and water and transferred into environmentally controlled enclosures (Betatech Inc.) at 8e10 weeks of age with an ambient temperature of initially 16 C. The ambient temperatures within the enclosures were decreased by 2 C every day until 4 C ambient temperature was established. Gcgr BATÀ/À (BAT-specific Gcgr knockout) mice and controls (Cre, Floxed) were generated by crossing hemizygous Myf5-Cre mice (007893, The Jackson Laboratory, Bar Harbour, ME) with floxed Gcgr mice [34, 35] . Experiments were carried out in all groups of male mice (unless otherwise stated) that were on a C57BL/6J background. However, because the control groups were phenotypically similar with respect to body weight, fat mass, and glucose homeostasis, all control data are presented as a single pooled group (Myf5-Cre and Gcgr flox/flox mice). Mice were euthanized by CO 2 
Blood collection
All blood samples (w50e100 ml) during metabolic tests were collected from tail vein into lithium coated Microvette tubes (Sarstedt, Numbrecht, Germany) and mixed with a 10% volume of TED (5000 kIU/ ml Trasylol (Bayer), 32 mM EDTA, and 0.01 mM Diprotin A (Sigma)). Samples were kept on ice and plasma was collected by centrifugation (>12, 000 rpm at 4 C for 5 minutes) and stored at -80 C. 2.6. RNA isolation and gene expression assays Tissue samples were homogenized in Tri Reagent (Molecular Research Center, Cincinnati, ON) using a TissueLyser II system (Qiagen, Germantown, MD), and total RNA was extracted using the manufacturer's protocol. First strand cDNA was synthesized from DNase I-treated total RNA using the SuperScript III and random hexamers (Thermo Fisher Scientific, Markham, ON). Gene expression levels were quantified by real-time PCR using a QuantStudio System and TaqMan Gene Expression Master Mix and Assays (Thermo Fisher Scientific). Primer/probes were purchased from Thermo Fisher Scientific and are listed in Supplementary Table 1 . qPCR data were analyzed by 2 -DDCt method, and expression levels for each gene were normalized to either Actb (b-actin) or Tbp (TATA-box-binding protein).
Detection of full-length mouse
Gcgr mRNA transcripts Full-length (w1.4 kb) mouse Gcgr PCR products were amplified from cDNA using the following primers: forward 5 0 -CTG CTG CTG CTG CTG TTGG -3 0 and reverse 5 0 -ACC TTG GGA GAC TAC TGGC-3 0 , separated on an agarose gel, transferred to a nylon membrane, and hybridized overnight with an internal 32 P-labeled mouse Gcgr-specific oligonucleotide probe (5 0 -AAT GCC ACC ACA ACC TAA GC-3'-). The membrane was washed and then imaged using a Storm 860 Phosphor Screen and Quantity One imaging software (Bio-Rad, Hercules, CA). Actb was used as a control for RNA integrity of samples.
Cell culture: BAT cell line
Immortalized BAT cells were a gift from Dr. Bruce Spiegelman's laboratory (Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA) [37] . On Day 0, BAT preadipocyte cells were plated onto collagen coated plates (<0.006%) containing growth media (DMEM (4.5 g/l glucose, L-glutamine, Wisent, St. Bruno, QC) with 20% FBS (Wisent), 1% Sodium Pyruvate (100 mM, Sigma), <0.01% HEPES (1M, Wisent), and 1% Penicillin-Strep (Wisent)) and grown until they achieved a healthy mono-layer (w90e95% confluent). After reaching confluence, on Day 1, growth media was replaced with induction media (DMEM with 10% FBS, 1% Sodium Pyruvate, HEPES and 1% Penicillin-Strep supplemented with 2 mg/ml dexamethasone (Sigma), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma), 125 mM indomethacin (Sigma), 10 mg/ml or 1.7 mM insulin (Sigma), and 1 nM T3 (Sigma). After 48 h of induction, on Day 3, media was changed to maintenance media (DMEM (25 mM glucose) with 10% FBS, 1% Sodium Pyruvate, <0.01% HEPES, and 1% Penicillin-Strep supplemented with 10 mg/ml or 1.7 mM insulin and 1 nM T3, (Sigma), until cells were fully differentiated by Day 7 . Fresh media was added to cells as required. All experiments, unless otherwise stated, were performed on fully differentiated cells on Day 7. To assess the effects of GCG on gene expression or lipolysis, BAT cells were differentiated for 7 days in collagen coated 12-well cell culture dishes (initiated at a density of 40,000 cells per well) in 1 ml of growth media. On Day 7, cells were nutrient-media starved for 3 h in FBS-free DMEM media devoid of all supplements except sodium pyruvate and HEPES. For gene expression assay, BAT cells in each well were treated with media (1 ml) containing either acidified PBS or GCG 100 nM for 1 or 4 h and RNA was isolated by adding 1 ml of Trireagent directly into plates and homogenizing cells by repetitive pipetting. For analysis of lipolysis, BAT cells were serum starved for 3 h. Media was then changed to warm (37 C) filtered Kreb's buffer (12 mM Hepes, 121 mM NaCl, 4.9 mM KCL, 1.2 mM MgSO4, 0.33 mM CaCl2, 3% BSA, 3 mM glucose) containing either acidified PBS or GCG (10 nM-1 mM) for 2 h. Media was then collected into 1.5 ml Eppendorf tubes and frozen at À20 C. Free glycerol in cell media was measured using a free glycerol assay kit (Cat# F6428, Sigma), and normalized to protein content (measured using Bradford assay kit (Bio-Rad, Montreal, QC).
2.9. siRNA-induced knockdown of Gcgr mRNA in BAT cells On Day 0, BAT cells were plated at a density of 80,000 cells per well in 6-well tissue culture dishes containing growth media. Cells were differentiated as described above until Day 4 , when differentiated BAT cells were trypsinized, centrifuged and re-suspended in antibiotic-free maintenance media. Differentiated BAT cells were transfected with siRNA duplexes (Universal scrambled negative control (Origene, Rockville, MD) sequence, Cat# SR30004-CGUUAAUCGCGUAUAAUACGCGUAT) or Gcgr (Origene duplex sequence, Cat# SR415672A-GGAGAAGCCAUGUUAUCUAUGAACT)) diluted in OptiMEM to a final concentration of 50 mM in 1 ml of media using Lipofectamine RNAiMAX Reagent (Thermo Fisher Scientific), following the manufacturer's protocol. Transfection complexes were added to collagen coated 12-well plates containing 800,000e1,000,000 cells per well suspended in antibiotic-free maintenance media. Maintenance media was replaced every 24 h until Day 7 when cells were harvested for RNA isolation as described above.
Histological analysis
Adipose tissues were fixed in 10% buffered formalin for a minimum of 48 h, and then tissues were transferred into 70% ethanol until processing. Samples were paraffin-embedded, sectioned at 4 mm thickness, slide-mounted, and stained with hematoxylin and eosin. Sections were scanned using the ScanScope CS System (Aperio Tehcnologies, Sausalito, CA) and digital images captured at 100 mM using ScanScope Software (Aperio Technologies).
Statistics
Data are represented as the mean AE SEM. Statistical significance was determined by one-way ANOVA (post-hoc test Bonferroni), two-way ANOVA (post-hoc test Tukey), paired ( Figure 2D and Figure S2C ) or unpaired two-tailed Student's t-test using GraphPad Prism version 8 Software (San Diego, CA). A p value < 0.05 was considered statistically significant. Figure 1A ) including mesenteric white adipose tissue (mWAT), inguinal (iWAT), epididymal (eWAT), retroperitoneal (rWAT), and interscapular brown adipose tissue (iBAT) ( Figure 1A ), corresponding to full length Gcgr mRNA ( Figure 1B ), albeit at levels 1,000e10,000 fold lower than in liver ( Figure 1A ). Gcgr mRNA was also detected in a differentiated BAT cell line ( Figure S1A ), associated with induction of Ucp1 expression ( Figure S1B ). GCG treatment increased levels of Ucp1, Ppargc1a, and Cepba mRNA in BAT cells studied at Day 2 of differentiation ( Figure S1C ) and Ucp1, Ppargc1a, Cidea, Elovl3, Ptgs2, and Fgf21 mRNA transcripts were increased by GCG on Day 7 ( Figure 1C) . Conversely, siRNA-mediated knockdown of Gcgr expression reduced levels of Ucp1, Ppargc1a, Elovl3, Cebpa, Cidea, Lipe, Ardb3, and Fgf21 mRNA transcripts after 2 or 7 days of differentiation ( Figure 1D and Figure S1D ). CL316,243 was administered to BAT cells in a separate experiment, demonstrating selective induction of mRNA transcripts in response to adrenergic activation ( Figure S1E ). GCG also directly increased lipolysis in a dose-dependent manner in BAT cells (Figure 1E ), through mechanisms requiring the Gcgr ( Figure S1F ). Hence, BAT cells express a functional canonical GCGR directly coupled to thermogenic gene expression and lipolysis.
RESULTS
3.1.
3.2. GCG increases oxygen consumption through UCP1-independent, FGF21-dependent pathways Considerable evidence demonstrates that acute GCG administration rapidly increases circulating levels of FGF21 in mice and humans [31, 38] . Indeed, acute GCG administration increased oxygen consumption in mice through mechanisms requiring hepatic farnesoid X receptor signaling and FGF21 [32] . We observed that GCG (0.01e 0.5 mg/kg) administration rapidly increased oxygen consumption in a dose-dependent manner in RCD-fed WT mice housed at RT (Figure 2A and Figure S2A -B) and in mice fed a HFD ( Figure S2C ). GCG also increased oxygen consumption in WT mice acclimatized to either cold (4 C, Figure 2B ) or thermoneutral (30 C, Figure 2C ) temperatures for 2 weeks while fed a HFD. Acute GCG administration to mice also increased oxygen consumption ex vivo in both iBAT and liver explants ( Figure 2D and Figure S2D , respectively). GCG increased oxygen consumption to similar levels in Ucp1 þ/þ vs. Ucp1 À/À mice, whereas the response to the b-3-adrenergic receptor agonist (CL316,243) was blunted in Ucp1 À/À mice ( Figure 2E ). As circulating FGF21 levels rose rapidly following GCG administration ( Figure S2E) , we assessed the effect of GCG administration in Fgf21 null mice. In contrast to observations in Ucp1 null mice, the GCG-induced rise in oxygen consumption was blunted in Fgf21 À/À mice compared to Fgf21 þ/þ control mice ( Figure 2F ), consistent with recent findings [32] .
Genetic reduction of iBAT Gcgr expression does not regulate body weight and composition
To determine whether the BAT Gcgr contributes to the physiological control of energy homeostasis or the acute response to GCG agonism, we crossed Gcgr flox/flox with Myf5-Cre mice to generate Gcgr BATÀ/À mice ( Figure 3A) . Consistent with the expression domain of Myf5, levels of Gcgr mRNA transcripts were lower in rWAT and in BAT from Gcgr BATÀ/À mice, whereas Gcgr expression was not affected in liver, kidney, and jejunum ( Figure 3B, Figure S3A ). No differences in body weight ( Figure 3C ), fat and lean mass ( Figure 3D) , adipose tissue or organ weights ( Figure 3E, Figure S3B ), or adipose tissue histology ( Figure 3F ) were detected in RCD-fed or in HFD-fed mice (Figure 3GeJ, Figure S3C ) housed at RT for 32 weeks. Body temperatures were not different in RCD-fed 8 or 30 week old Gcgr BATþ/þ vs. Gcgr BATÀ/À mice after a 16 h overnight fast or after 30 weeks on RCD or HFD ( Figure S3D and S3E) . Basal oxygen consumption was not different in iBAT explants from Gcgr BATþ/þ and Gcgr BATÀ/À mice after 32 weeks on a RCD ( Figure S3F) . Hence, the iBAT Gcgr is dispensable for control of body weight in response to RCD or HFD-feeding.
3.4. Loss of the iBAT Gcgr does not impact food intake, energy expenditure, or glucose homeostasis Food intake, energy expenditure, and the respiratory exchange ratio (RER) were not different in older Gcgr BATþ/þ vs. Gcgr BATÀ/À mice maintained on RCD (Figure 4AeC) or HFD (Figure 4FeH) . Moreover, acute administration of GCG to Gcgr BATþ/þ and Gcgr BATÀ/À mice fed a RCD did not show any differences in oxygen consumption ( Figure 4D ). Activity levels were not different ( Figure S4A and S4D ) and the levels of mRNA transcripts for genes regulating thermogenesis or adipose tissue differentiation were similar in adipose tissue depots from RCD-or HFD-fed Gcgr BATþ/þ vs. Gcgr BATÀ/À mice ( Figure 4E ,I, Figure S4B ,C and S4E,F). Although small increases in plasma GLP-1 and GCG levels were detected in Gcgr BATÀ/À fed a RCD ( Figure S5B and S5F), no differences in glucose or insulin tolerance, plasma levels of insulin, GCG, and GIP, or adipose tissue gene expression were detected in young RCD-or HFD-fed Gcgr BATþ/þ vs. Gcgr BATÀ/À mice ( Figure S5A-N) . Similarly, oral and intraperitoneal glucose tolerance ( Figure 5A BATþ/þ and Gcgr BATÀ/À mice fed RCD and housed at rt. n ¼ 8e9. (E) iBAT mRNA transcript levels for genes regulating thermogenic, mitochondrial, and differentiation processes in Gcgr BATþ/þ and Gcgr BATÀ/À mice fed RCD for 32 weeks housed at RT, n ¼ 4e6.
Food intake (F), basal energy expenditure (G) and RER (H) measured over 36 h in Gcgr
BATþ/þ and Gcgr BATÀ/À mice housed at rt and fed RCD for 28 weeks (F) or 16 weeks (G, H).
n ¼ 6e12. (I) iBAT mRNA transcript levels for genes regulating thermogenic, mitochondrial and differentiation processes in Gcgr BATþ/þ and Gcgr BATÀ/À mice fed HFD for 32 weeks and housed at RT, n ¼ 4e6. BW ¼ body weight. Tbp was used as a housekeeping gene for relative mRNA expression levels. iBAT ¼ interscapular brown adipose tissue.
Normal metabolic adaptation to cold exposure in Gcgr
BATÀ/À mice To determine whether the BAT GCGR is important for the metabolic adaptation to chronic cold exposure, we studied HFD-fed Gcgr
and Gcgr BATÀ/À mice maintained at 4 C for w12 weeks. Body weights (Figure 6A ), fat and lean mass and tissue weights ( Figure 6B,C) , adipose tissue morphology ( Figure 6D ), food intake, energy expenditure, and respiratory exchange ratio (RER) (Figure 6EeG) were not different between cold-exposed HFD-fed Gcgr BATþ/þ vs. Gcgr BATÀ/À mice.
Similarly, oral and intraperitoneal glucose tolerance ( Figure 6H,I ), insulin and lipid tolerance ( Figure 6J ,K), plasma levels of TGs and NEFAs ( Figure 6L , M), iBAT TGs ( Figure 6N ) and iBAT gene expression profiles ( Figure 6O ) were also not different between Gcgr BATþ/þ and Gcgr BATÀ/À mice exposed to cold and fed a HFD. Furthermore, body temperature ( Figure S6A ), tissue weights ( Figure S6B ), basal iBAT oxygen consumption ( Figure S6C ), and activity levels ( Figure S6D ) were similar in HFD-fed Gcgr BATþ/þ and Gcgr BATÀ/À mice after 10e12 weeks of cold exposure. Collectively, these results demonstrate that BAT GCGR is dispensable for the regulation of energy (food intake, energy expenditure, body composition), glucose and lipid metabolism, both in young and old mice, and in mice fed a RCD, or a HFD, and studied at different ambient temperatures.
DISCUSSION
Considerable experimentation links acute GCG administration to increased core body temperature [39] , BAT blood flow [28] , BAT mass, and thermogenic activity [17, 23] , as well as enhanced energy expenditure in rodents and humans [13, 40] . Moreover, several studies have demonstrated direct actions of GCG on BAT [11, 41] , raising the possibility that GCGR activity contributes to the endogenous control of whole body energy expenditure. Herein, we refine the mechanistic importance of these findings by using mouse genetics to test the relative importance of the murine BAT GCGR for the acute response to GCG administration, and the long term physiological control of energy homeostasis. Pharmacological GCG agonism produces weight loss through reduction in food intake and via potentiation of thermogenic mechanisms to increase energy expenditure [3, 4] . Indeed, GCG-containing peptide multiagonists require a functional GCGR to reduce fat mass and generate weight loss in HFD-fed mice, actions reflecting a combination of reduced food intake and enhanced energy expenditure [42] . Similarly, the weight loss observed with the GCG-GLP-1 co-agonist MEDI0382 in preclinical studies was partially attributed to GCGR-dependent induction of energy expenditure [43] . Identification of the key tissues essential for the GCGR-dependent control of energy expenditure remains incomplete, and the available evidence supports a role for multiple organs, including liver and adipose tissue, in transducing GCGR-stimulated signals linked to enhanced oxygen consumption [3, 32] . Although GCG administration increased Ucp1 expression in BAT and increased Fgf21 mRNA transcripts in murine liver [12, 44] , our current data demonstrate that Ucp1 is not required for acute GCG induction of oxygen consumption. Consistent with recent independent studies, we confirm that the GCGinduced increase in oxygen consumption is only partially blunted in Fgf21 À/À mice [32] , implicating additional GCGR-dependent mechanisms contributing to the acute GCG-dependent enhancement of energy expenditure. Notably, glucagon administration may increase oxygen consumption in the liver, adipose tissue, and possibly other tissues [31] . Whether these actions, partially independent of FGF21, reflect additional recruitment of downstream mediators, or direct signaling from the GCGR to mitochondrial pathways, requires further exploration. Our analysis of relative Gcgr gene expression across a range of tissues revealed that levels of adipose tissue Gcgr mRNA transcripts were not abundant, being several orders of magnitude lower in WAT compared to liver, and even lower in BAT. Nevertheless, acute administration of GCG to mice increased oxygen consumption not only in the liver, but also in BAT. Furthermore, our studies with BAT cells in vitro demonstrated that enhanced or reduced Gcgr expression was associated with the regulation of lipolysis and the expression of genes linked to the control of energy expenditure. Hence, to identify a role for the BAT Gcgr in the pharmacological response to acute Gcgr administration in vivo, we generated and characterized Gcgr BATÀ/À mice. Unexpectedly, GCG administration robustly induced oxygen consumption to a similar extent in Gcgr BATþ/þ vs. Gcgr BATÀ/À mice. Taken together, these results suggest that the murine BAT GCGR is not an important molecular target for the acute pharmacological actions of GCG administration, findings consistent with the lack of increased neck temperature or BAT glucose uptake in healthy male humans following transient GCG infusion [15] . The generation of mice with a marked reduction of BAT Gcgr expression provided an opportunity to determine the physiological importance of the GCGR within the cellular domains targeted by Myf5-Cre. Notably, the BAT Gcgr is not required for control of body weight, adiposity, core temperature, or energy expenditure, either when housed at RT or 4 C. Moreover, we detected no differences in these parameters in mice maintained on a RCD or HFD. Furthermore, glucose homeostasis and lipid tolerance was not different in Gcgr BATþ/þ vs. Gcgr BATÀ/À mice, whether maintained in the cold, or at RT and studied after exposure to RCD or HFD conditions. Hence, the totality of the data is consistent with the very low level of BAT Gcgr expression and reveals that the BAT Gcgr is dispensable for metabolic adaptation to energy excess or a cold environment.
LIMITATIONS
Our studies have several limitations. First, we focused on acute pharmacological GCG administration in young male C57Bl/6 mice and cannot rule out a role for the BAT GCGR in transduction of a component of weight loss observed with more sustained GCGR agonism in a wider range of mice and conditions [32] . Second, we did not study mice with experimental diabetes; hence, our conclusions are limited to mice analyzed under RCD and HFD feeding. Third, we did not examine the actions of GCG-containing multi-agonists, and it is possible that BAT GCGR activation may be more important when GCG is combined with one or more peptides with complementary metabolic activity. Nevertheless, within the context of these limitations, the results of our studies are quite conclusive and suggest that the BAT GCGR is dispensable for the acute metabolic response to GCG administration and the physiological control of energy homeostasis.
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